- Home
- EXK vs TVTX Comparison
EXK vs TVTX Comparison
Compare EXK & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXK
- TVTX
- Stock Information
- Founded
- EXK 1981
- TVTX 2008
- Country
- EXK Canada
- TVTX United States
- Employees
- EXK N/A
- TVTX N/A
- Industry
- EXK Precious Metals
- TVTX Biotechnology: Pharmaceutical Preparations
- Sector
- EXK Basic Materials
- TVTX Health Care
- Exchange
- EXK Nasdaq
- TVTX Nasdaq
- Market Cap
- EXK 1.7B
- TVTX 1.5B
- IPO Year
- EXK N/A
- TVTX N/A
- Fundamental
- Price
- EXK $5.98
- TVTX $21.64
- Analyst Decision
- EXK Strong Buy
- TVTX Strong Buy
- Analyst Count
- EXK 3
- TVTX 16
- Target Price
- EXK $8.33
- TVTX $34.53
- AVG Volume (30 Days)
- EXK 11.1M
- TVTX 1.9M
- Earning Date
- EXK 11-04-2025
- TVTX 10-30-2025
- Dividend Yield
- EXK N/A
- TVTX N/A
- EPS Growth
- EXK N/A
- TVTX N/A
- EPS
- EXK N/A
- TVTX N/A
- Revenue
- EXK $247,749,000.00
- TVTX $333,865,000.00
- Revenue This Year
- EXK $85.98
- TVTX $83.26
- Revenue Next Year
- EXK $66.91
- TVTX $43.19
- P/E Ratio
- EXK N/A
- TVTX N/A
- Revenue Growth
- EXK 11.64
- TVTX 87.94
- 52 Week Low
- EXK $2.82
- TVTX $9.44
- 52 Week High
- EXK $6.74
- TVTX $25.29
- Technical
- Relative Strength Index (RSI)
- EXK 55.89
- TVTX 78.22
- Support Level
- EXK $5.63
- TVTX $17.27
- Resistance Level
- EXK $6.74
- TVTX $19.57
- Average True Range (ATR)
- EXK 0.32
- TVTX 0.99
- MACD
- EXK 0.04
- TVTX 0.33
- Stochastic Oscillator
- EXK 47.59
- TVTX 88.44
About EXK Endeavour Silver Corporation (Canada)
Endeavour Silver Corp is a Canadian mineral company engaged in the evaluation, acquisition, exploration, development, and exploitation of precious metal properties in Mexico and Chile. The Company has two operating mining segments which are located in Mexico, Guanacevi and Bolanitos. The company has one development project in Mexico, Terronera, as well as Exploration and Corporate segments. The Exploration segment consists of projects in the exploration and evaluation phases in Mexico, Chile, and the USA.
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.